Navigation Links
TriReme Medical Lines Up Asian Strategy With Key Appointment of New Board Members
Date:5/9/2011

PLEASANTON, Calif., May 9, 2011 /PRNewswire/ -- TriReme Medical, Inc. (TriReme), a leading developer of innovative catheters and stents for the treatment of complex vascular disease, announced today the appointment of Mr. Supratim Bose and Mr. Michael Kleine to their Board of Directors.

Mr. Bose, Founder and CEO of Bose Consulting Group, is based in Singapore and was until recently Company Group Chairman at Johnson & Johnson with responsibilities for all of the Medical Devices & Diagnostics franchises across the Asia-Pacific Region.  Mr. Bose was also a member of the Worldwide Group Operating Committee at Johnson & Johnson Medical Devices & Diagnostics Group.

Mr. Kleine was previously President and CEO of Biosensors International (SGX), a medical device company listed on the Singapore Stock Exchange.  He brings vast experience in medical devices having held CEO and President positions at Microvention, Thermo Cardiosystems, Sorin Biomedical and Bird Medical.

"TriReme is developing an exciting range of innovative and differentiated devices and I am excited to help lead their Asian centered strategy," commented Mr. Bose.  Mr. Kleine added, "TriReme has created a truly global vision and its expansion is supported by a strong pipeline of unique products."

"Supratim and Mike's enormous experience with the Asian markets provide an extended dimension to both our Board and management teams.  TriReme is honored to have the endorsement of both industry veterans who support and share our global vision of medtech growth and development in Asia," said Eitan Konstantino, PhD, President and Chief Executive Officer of TriReme.

About TriReme Medical, Inc.

Based in Pleasanton, California, TriReme Medical, Inc. is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The Company's novel balloon and stent therapies are specifically designed for large, unmet clinical needs.


'/>"/>
SOURCE TriReme Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. TriReme Medical Announces Japanese Alliance
2. TriReme Medical Announces $17 Million Series D Financing
3. TriReme Medical, Inc. Receives FDA 510K Clearance for Glider(TM) PTA Balloon Catheter
4. TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System
5. Frantz Medical Group Announces the Promotion of Stephanie Harrington to Chief Operating Officer
6. Major Medical Diagnostics Manufacturer Signs Agreement to Use AmbiCom Wireless Solution in Its Urinalysis Product Line
7. Samsung Medison Pledges to Become a World-Class Medical Device Company
8. Varian Medical Systems Spotlights Fully Integrated Intensity Modulated Proton Therapy at PTCOG 2011 Meeting
9. Varian Medical Systems Spotlights Advanced Radiosurgery Systems at ISRS Congress in Paris, May 8-12
10. China Medical Technologies to Present at Jefferies 2011 Global Healthcare Conference on June 7, 2011
11. Winner Medical Group Inc. to Host Second Quarter 2011 Earning Conference Call on Wednesday, May 11, 2011 at 08:30 a.m. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... Southern Illinois University School of Dental ... Illinois State Dental Society (ISDS) Foundation’s Mission of Mercy (MOM). They will host ... Collinsville. , They expect to treat approximately 2,000 patients from Illinois, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... a not-for-profit organization responsible for clinical transfusion research programs and for the blood ... Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently ...
(Date:6/23/2016)... ... June 23, 2016 , ... SyncDog, Inc. , ... security software, is featured in the current issue of Silicon Review ... with innovative technology solutions and features them in their magazine. The magazine allows ...
(Date:6/23/2016)... ... 23, 2016 , ... Horizon Blue Cross Blue Shield of ... from the crushing burden of sky-high health care costs, Superior Court of New ... ( http://www.judiciary.state.nj.us/opinions/a2913-15a2929-15.pdf ) the court provided some analysis of the contracts between ...
(Date:6/23/2016)... ... ... A key metric of this success is the popularity of the Leafedin.org service ... areas that lack the kind of technology and networking framework that LeafedIn.org provide, where ... the marijuana industry, no matter how small or large, and more importantly no matter ...
Breaking Medicine News(10 mins):